MMP14 and neuroblastoma: Since our preliminary data revealed that administration of DNA methyltransferase inhibitor resulted in no significant changes in miR-337-3p-induced transcriptional repression of MMP-14 in NB cells, we ruled out the possible involvement of aberrant promoter hypermethylation in this process.